A life-sciences executive and author working across diagnostics, biopharma and corporate strategy.
THE PERSPECTIVE
Questions shaped by practical work.
His work has moved between assay science, product development and business leadership. That experience keeps a practical question close: what does a result establish, whose decision does it change and what still has to be supplied for it to matter?
His books ask how organizations decide what is possible, what is worth building and what they can responsibly promise. They develop these questions through public records and case comparisons, with his professional experience providing the vantage from which he writes.
EXPERIENCE
Experience across science and business.
01BIO-RAD LABORATORIES
Scientific, product and business leadership
Moved from scientific and product roles into business leadership across diagnostics and life-science tools.
02PROZYME
Chief executive
Led a life-science company through its acquisition by Agilent Technologies.
03AGILENT TECHNOLOGIES
Pharma and biopharma strategy
Led pharma and biopharma end-market strategy, connecting scientific developments with market needs and choices about commercial capability.
04FAPON GROUP
Strategy and partnerships
Vice President of Strategy and Partnerships, working across diagnostics and biotechnology.
He holds a Ph.D. in physical chemistry.
THE BOOKS
Explore the questions through the books.
Diagnostics, therapeutic categories, strategic judgment and public preparedness offer different places to begin.
